{"id":"placebo-topical-cream","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108947","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are inert preparations used as controls in clinical trials or, in some cases, marketed as topical creams. Any observed clinical benefit derives from patient expectation, the ritual of application, and psychological mechanisms rather than pharmacological action. The cream base itself may provide minor symptomatic relief through emollient or occlusive properties, but the product is not intended to have active drug-mediated effects.","oneSentence":"A placebo topical cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:01:28.932Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07244991","phase":"NA","title":"Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2026-01-04","conditions":"Dental Caries, Streptococcus Mutans, Tooth Demineralization","enrollment":200},{"nctId":"NCT03372811","phase":"PHASE2","title":"Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)","status":"COMPLETED","sponsor":"Psoriasis Research Institute of Guangzhou","startDate":"2015-06-11","conditions":"Psoriasis Vulgaris, Topical Administration","enrollment":88},{"nctId":"NCT07257029","phase":"PHASE2","title":"Topical Ketotifen 0.25% for Secondary Vestibulodynia","status":"RECRUITING","sponsor":"Center for Vulvovaginal Disorders","startDate":"2026-01-02","conditions":"Provoked Vestibulodynia, Secondary Provoked Vestibulodynia, Vulvodynia","enrollment":54},{"nctId":"NCT06223659","phase":"PHASE2","title":"EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2023-12-19","conditions":"Cutaneous Melanoma, Merkel Cell Carcinoma, Skin Squamous Cell Carcinoma","enrollment":100},{"nctId":"NCT07454525","phase":"NA","title":"Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.","status":"NOT_YET_RECRUITING","sponsor":"AB Biotics, SA","startDate":"2026-02","conditions":"Skin, Skin Microbiome, Skin Microbiota","enrollment":45},{"nctId":"NCT07438509","phase":"PHASE4","title":"Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema","status":"NOT_YET_RECRUITING","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2026-03-01","conditions":"Atopic Dermatitis (AD), Atopic Eczema","enrollment":270},{"nctId":"NCT05342519","phase":"PHASE2","title":"Daily Topical Rapamycin for Vitiligo","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2022-07-28","conditions":"Vitiligo","enrollment":20},{"nctId":"NCT06286397","phase":"PHASE2","title":"Topical Anti-Androgens in Pilonidal Sinus Disease","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-01-10","conditions":"Pilonidal Disease, Pilonidal Disease of Natal Cleft, Pilonidal Sinus","enrollment":75},{"nctId":"NCT07079969","phase":"PHASE2","title":"Effects of Photobiomodulation and Topical Diclofenac on Inflammation and Pain in Knee Osteoarthritis (EPIC-KO)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-04","conditions":"Knee Pain Chronic","enrollment":32},{"nctId":"NCT07426120","phase":"PHASE3","title":"Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)","status":"RECRUITING","sponsor":"Psoriasis Research Institute of Guangzhou","startDate":"2026-02-01","conditions":"Psoriasis Vulgaris, Topical Administration, Phase III","enrollment":300},{"nctId":"NCT05317364","phase":"PHASE4","title":"Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2022-07-14","conditions":"Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence","enrollment":38},{"nctId":"NCT05413811","phase":"NA","title":"Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-03-22","conditions":"Cervical Cancer, CIN2, CIN3","enrollment":180},{"nctId":"NCT03972592","phase":"PHASE2","title":"Topical Sirolimus in Cutaneous Lymphatic Malformations","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2019-06-05","conditions":"Vascular Malformations, Lymphatic Malformation","enrollment":55},{"nctId":"NCT07403942","phase":"NA","title":"The Skin Anti-Aging Effects of Vitamin K2 (MK-7): a Clinical Split-Face/Neck Trial","status":"COMPLETED","sponsor":"Nanjing Ascend Biotech Technology Co., Ltd.","startDate":"2024-12-26","conditions":"Skin Aging of Face and Neck","enrollment":36},{"nctId":"NCT07063615","phase":"NA","title":"A Clinical Study to Assess the Safety and Effectiveness of Scalp Cream for Symptom Relief and Microbiome Balance in Mild-moderate Seborrheic Dermatitis Patients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-07-21","conditions":"Seborrheic Dermatitis","enrollment":34},{"nctId":"NCT07111156","phase":"NA","title":"A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wrinkles, Fine Lines, and Dark Spots.","status":"ACTIVE_NOT_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-10-16","conditions":"Fine Lines, Wrinkles, Facial Sign of Aging","enrollment":81},{"nctId":"NCT06888362","phase":"PHASE1","title":"Trial to Investigate GZ21T in Healthy Volunteers","status":"COMPLETED","sponsor":"Genzada Pharmaceuticals USA, Inc.","startDate":"2024-08-19","conditions":"Actinic Keratosis","enrollment":41},{"nctId":"NCT05289804","phase":"PHASE1, PHASE2","title":"Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment","status":"COMPLETED","sponsor":"University of Dublin, Trinity College","startDate":"2022-09-01","conditions":"Mild Cognitive Impairment, Memory Impairment, Memory Disorders in Old Age","enrollment":80},{"nctId":"NCT05212246","phase":"PHASE3","title":"Basal Cell Carcinoma Chemoprevention Trial","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-05-01","conditions":"Basal Cell Carcinoma","enrollment":1630},{"nctId":"NCT07352306","phase":"PHASE4","title":"Topical Diacerein in Psoriasis Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-02-01","conditions":"Psoriasis Vulgaris","enrollment":60},{"nctId":"NCT05388058","phase":"PHASE2","title":"Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-06-09","conditions":"Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm","enrollment":40},{"nctId":"NCT07345390","phase":"PHASE2","title":"Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Jiangxi Kvvit Pharmaceutical Co., Ltd.","startDate":"2026-01-10","conditions":"Acne Vulgaris","enrollment":180},{"nctId":"NCT07333300","phase":"NA","title":"Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application).","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2026-01-04","conditions":"Atopic Dermatitis (AD)","enrollment":20},{"nctId":"NCT07323719","phase":"NA","title":"Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-05-30","conditions":"Atopic Dermatitis (AD)","enrollment":100},{"nctId":"NCT06966206","phase":"PHASE3","title":"Multiprofen-CC to Reduce Pain in Hand Arthritis","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2026-01-01","conditions":"Hand Osteoarthritis","enrollment":42},{"nctId":"NCT03568318","phase":"PHASE3","title":"A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2018-08-09","conditions":"Atopic Dermatitis","enrollment":1533},{"nctId":"NCT06737406","phase":"NA","title":"Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart","status":"RECRUITING","sponsor":"Mazandaran University of Medical Sciences","startDate":"2025-05-30","conditions":"Common Warts","enrollment":60},{"nctId":"NCT06742957","phase":"PHASE3","title":"Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2024-12-17","conditions":"Plaque Type Psorisis","enrollment":560},{"nctId":"NCT04091022","phase":"PHASE2","title":"Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-01-18","conditions":"Non-melanoma Skin Cancer","enrollment":64},{"nctId":"NCT07288021","phase":"PHASE4","title":"Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)","status":"RECRUITING","sponsor":"Bnai Zion Medical Center","startDate":"2024-02-05","conditions":"Labor, Induced","enrollment":200},{"nctId":"NCT06202989","phase":"PHASE3","title":"Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty","status":"RECRUITING","sponsor":"KAZM Pharmaceuticals Inc.","startDate":"2024-09-09","conditions":"Postsurgical Pain","enrollment":288},{"nctId":"NCT04669093","phase":"NA","title":"Individual Differences in Placebo Analgesic Effects","status":"NOT_YET_RECRUITING","sponsor":"Trustees of Dartmouth College","startDate":"2026-09-30","conditions":"Healthy","enrollment":60},{"nctId":"NCT05190770","phase":"PHASE2","title":"A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-12-15","conditions":"Breast Cancer, Breast Cancer Stage, Breast Cancer Stage I","enrollment":18},{"nctId":"NCT07260656","phase":"EARLY_PHASE1","title":"Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain","status":"NOT_YET_RECRUITING","sponsor":"Carilion Clinic","startDate":"2025-12","conditions":"Diabetic Neuropathies, Painful, Diabetic Foot, Diabetic Peripheral Neuropathy","enrollment":80},{"nctId":"NCT01886794","phase":"PHASE4","title":"Hormonal Status on Blood Flow and Tissue in Pelvic Organ Prolapse","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2013-06-06","conditions":"Pelvic Floor Disorders","enrollment":7},{"nctId":"NCT01802086","phase":"NA","title":"Emla-Cream as Pain Relief During Pneumococcal Vaccination","status":"COMPLETED","sponsor":"Beatrice Olsson Duse","startDate":"2013-05","conditions":"Children, Pain","enrollment":72},{"nctId":"NCT07162454","phase":"NA","title":"Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy","status":"COMPLETED","sponsor":"Universidad Complutense de Madrid","startDate":"2024-11-01","conditions":"Xerosis Cutis, Neuropathic Pain Associated With Diabetic Peripheral Neuropathy","enrollment":23},{"nctId":"NCT07049068","phase":"PHASE1","title":"Comparison of Nicotinamide Treatments for Actinic Keratosis","status":"COMPLETED","sponsor":"Federal University of Rio Grande do Sul","startDate":"2022-02-01","conditions":"Actinic Keratoses","enrollment":74},{"nctId":"NCT05860881","phase":"PHASE3","title":"Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Melanoma and Skin Cancer Trials Limited","startDate":"2024-02-09","conditions":"Solid Organ Transplant Recipients, Skin Cancer","enrollment":146},{"nctId":"NCT06880276","phase":"PHASE3","title":"Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis","status":"RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-05-16","conditions":"Atopic Dermatitis","enrollment":360},{"nctId":"NCT04896385","phase":"PHASE2","title":"A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA)","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2021-06-23","conditions":"Vitiligo","enrollment":60},{"nctId":"NCT07072611","phase":"EARLY_PHASE1","title":"Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants","status":"RECRUITING","sponsor":"Noxopharm Limited","startDate":"2025-07-14","conditions":"Cutaneous Lupus Erythematosus","enrollment":32},{"nctId":"NCT04611347","phase":"PHASE2","title":"Is Topical CBD Effective in Treating Thumb Joint Arthritis","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2020-07-28","conditions":"CBD, Hand Osteoarthritis","enrollment":18},{"nctId":"NCT07034456","phase":"NA","title":"Sensory and Vascular Effects of Kinesio and Magnetic Tape in Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Patricia Beltra Lopez","startDate":"2025-07","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT06640946","phase":"PHASE4","title":"Pain Control for Laser Epilation in Pilonidal Disease","status":"COMPLETED","sponsor":"David Mooney","startDate":"2024-11-01","conditions":"Pilonidal Disease","enrollment":20},{"nctId":"NCT06771076","phase":"NA","title":"Effects of a CBD and Natural Ingredients Cream on the Chronic Pain of Triathletes, Runners, Cyclists, and Swimmers","status":"COMPLETED","sponsor":"University of Vic - Central University of Catalonia","startDate":"2025-01-18","conditions":"Tendinopathy, Injuries, Chronic Pain","enrollment":35},{"nctId":"NCT06969326","phase":"PHASE3","title":"Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy","status":"RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-05-01","conditions":"Postoperative Bleeding, Gender Dysphoria, Hysterectomy","enrollment":48},{"nctId":"NCT04329221","phase":"PHASE2","title":"Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01-01","conditions":"Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer","enrollment":""},{"nctId":"NCT02863068","phase":"PHASE2","title":"Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers","status":"TERMINATED","sponsor":"caterina P minniti","startDate":"2018-04-06","conditions":"Sickle Cell Disease","enrollment":18},{"nctId":"NCT04642287","phase":"PHASE2","title":"Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01","conditions":"Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses","enrollment":""},{"nctId":"NCT04313400","phase":"PHASE1, PHASE2","title":"Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Amytrx Therapeutics, Inc.","startDate":"2020-03-10","conditions":"Atopic Dermatitis","enrollment":91},{"nctId":"NCT06925035","phase":"NA","title":"Efficacy of Combined 1927nm Thulium Fiber Laser and Supramolecular Salicylic Acid in Photoaging Treatment","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2023-06-01","conditions":"Photo-aged Skin, Laser","enrollment":36},{"nctId":"NCT06925386","phase":"PHASE2","title":"The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2025-05-01","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT06108349","phase":"PHASE2","title":"Topical Cannabidiol for Treating Carpal Tunnel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2025-07-01","conditions":"Carpal Tunnel Syndrome","enrollment":20},{"nctId":"NCT06912139","phase":"PHASE3","title":"Topical Nitroglycerine for Prevention of Radial Artery Spasm","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy \"Victor Babes\" Timisoara","startDate":"2023-04-01","conditions":"Radial Artery Spasm","enrollment":100},{"nctId":"NCT05575882","phase":"NA","title":"Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.","status":"RECRUITING","sponsor":"NAOS Argentina S.A.","startDate":"2022-11-03","conditions":"Atopic Dermatitis, Eczema, Atopic","enrollment":100},{"nctId":"NCT06058000","phase":"PHASE2","title":"A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2023-11-13","conditions":"Atopic Dermatitis","enrollment":120},{"nctId":"NCT03761537","phase":"PHASE3","title":"Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-12-13","conditions":"Atopic Dermatitis","enrollment":277},{"nctId":"NCT05332366","phase":"PHASE2","title":"A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2022-04-19","conditions":"Frontal Fibrosing Alopecia","enrollment":35},{"nctId":"NCT00604890","phase":"PHASE1, PHASE2","title":"Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma","status":"COMPLETED","sponsor":"BPGbio","startDate":"2008-03","conditions":"Superficial Basal Cell Carcinoma","enrollment":186},{"nctId":"NCT01722812","phase":"PHASE2","title":"Cromoglicate in Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-11","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT05285943","phase":"PHASE4","title":"Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-11-04","conditions":"Radiodermatitis; Acute","enrollment":132},{"nctId":"NCT02427724","phase":"EARLY_PHASE1","title":"The Effect of Topical Anesthetics on Patients' Pain and Operative Experience During Treatment With QSwitched Laser","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2015-04","conditions":"Lentigo","enrollment":48},{"nctId":"NCT04883645","phase":"EARLY_PHASE1","title":"Neoadjuvant Imiquimod Immunotherapy for Oral Cancer","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2022-04-28","conditions":"Oral Squamous Cell Carcinoma","enrollment":16},{"nctId":"NCT05872477","phase":"PHASE2","title":"Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2023-09-05","conditions":"Vitiligo","enrollment":20},{"nctId":"NCT03943407","phase":"NA","title":"Characterization of the Toll-like Receptor 7-agonist Imiquimod 3.75% As a New Surrogate Model of Itch","status":"WITHDRAWN","sponsor":"Aalborg University","startDate":"2019-11-01","conditions":"Itch","enrollment":""},{"nctId":"NCT06687512","phase":"NA","title":"A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2024-11-20","conditions":"Atopic Dermatitis","enrollment":44},{"nctId":"NCT06673654","phase":"PHASE1","title":"A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2023-08-11","conditions":"Atopic Dermatitis","enrollment":476},{"nctId":"NCT06657352","phase":"NA","title":"Skin Efficacy Testing of Astrion Products","status":"COMPLETED","sponsor":"Chia Nan University of Pharmacy ＆ Science","startDate":"2022-11-28","conditions":"Skin Pigment, Skin Red","enrollment":150},{"nctId":"NCT04283292","phase":"PHASE4","title":"Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2020-12-01","conditions":"Cannabinoid Hyperemesis Syndrome","enrollment":20},{"nctId":"NCT04103814","phase":"PHASE2, PHASE3","title":"Effect of Topical CBD Cream for Degenerative Hallux Disorders","status":"TERMINATED","sponsor":"Rush University Medical Center","startDate":"2019-10-20","conditions":"Hallux Valgus, Hallux Rigidus","enrollment":11},{"nctId":"NCT05550337","phase":"PHASE3","title":"Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2022-09-19","conditions":"Acne Vulgaris","enrollment":807},{"nctId":"NCT06402630","phase":"PHASE2","title":"A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)","status":"COMPLETED","sponsor":"Soterios Ltd","startDate":"2022-03-23","conditions":"Alopecia Areata","enrollment":158},{"nctId":"NCT05649228","phase":"EARLY_PHASE1","title":"Thermosensitivity of a Topical Palmitated Formulation of Capsaicin","status":"COMPLETED","sponsor":"Carilion Clinic","startDate":"2022-12-13","conditions":"Pain Management","enrollment":52},{"nctId":"NCT06320327","phase":"NA","title":"Topical CBD's Effects on Soreness and Performance","status":"COMPLETED","sponsor":"Joseph Pastina","startDate":"2022-08-23","conditions":"Muscle Soreness","enrollment":30},{"nctId":"NCT06300008","phase":"NA","title":"Cetylated Fatty Acid for Reducing Pain After TKA","status":"RECRUITING","sponsor":"Thammasat University","startDate":"2024-02-12","conditions":"Postoperative Pain, Postoperative Inflammation","enrollment":80},{"nctId":"NCT06289946","phase":"PHASE2","title":"Topical Nitro or Placebo Pre-Cath","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2024-03-01","conditions":"Coronary Artery Disease","enrollment":256},{"nctId":"NCT06274905","phase":"NA","title":"Topical Anaesthesia in Cutaneous Head and Neck Surgery","status":"COMPLETED","sponsor":"University Hospital Waterford","startDate":"2023-02-20","conditions":"Pain, Acute, Head and Neck Cancer, Cutaneous Tumor","enrollment":124},{"nctId":"NCT05387707","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis","status":"TERMINATED","sponsor":"Cara Therapeutics, Inc.","startDate":"2022-08-16","conditions":"Pruritus, Atopic Dermatitis","enrollment":287},{"nctId":"NCT05098067","phase":"PHASE2","title":"Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy","status":"COMPLETED","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2022-05-24","conditions":"Hyperemesis Gravidarum, Nausea Gravidarum, Vomiting of Pregnancy","enrollment":30},{"nctId":"NCT03912259","phase":"PHASE3","title":"Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-12-19","conditions":"Atopic Dermatitis","enrollment":165},{"nctId":"NCT04484337","phase":"PHASE1","title":"Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2020-07-31","conditions":"HIV Infections","enrollment":138},{"nctId":"NCT06155578","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis","status":"UNKNOWN","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2024-01-02","conditions":"Systemic Sclerosis, Calcinosis","enrollment":20},{"nctId":"NCT05787743","phase":"NA","title":"Topical Palm Tocotrienols on Skin Biophysical Properties","status":"TERMINATED","sponsor":"Universiti Sains Malaysia","startDate":"2023-07-17","conditions":"Wrinkle","enrollment":41},{"nctId":"NCT03403621","phase":"PHASE1, PHASE2","title":"Hypertrophic Scar Prevention by Novel Topical Gel Application","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2018-03-05","conditions":"Hypertrophic Scar","enrollment":6},{"nctId":"NCT05003453","phase":"PHASE2, PHASE3","title":"The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of Eczema","status":"COMPLETED","sponsor":"RDC Clinical Pty Ltd","startDate":"2021-11-29","conditions":"Eczema, Atopic","enrollment":72},{"nctId":"NCT06137820","phase":"NA","title":"CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle","status":"UNKNOWN","sponsor":"Pharmanutra S.p.a.","startDate":"2022-11-18","conditions":"Ankle Injury or Chronic Trauma to the Ankle","enrollment":80},{"nctId":"NCT04020419","phase":"EARLY_PHASE1","title":"Natural Berry Extract Treatment of Hemangiomas","status":"TERMINATED","sponsor":"Gayle Gordillo","startDate":"2020-12-01","conditions":"Hemangioma","enrollment":12},{"nctId":"NCT04307862","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis","status":"UNKNOWN","sponsor":"Shulov Innovate for Science Ltd. 2012","startDate":"2019-12-29","conditions":"Atopic Dermatitis","enrollment":165},{"nctId":"NCT03826628","phase":"PHASE2, PHASE3","title":"Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex","status":"COMPLETED","sponsor":"Dermatology Specialties Limited Partnership","startDate":"2019-07-28","conditions":"Facial Angiofibroma, Tuberous Sclerosis","enrollment":107},{"nctId":"NCT05124275","phase":"PHASE2","title":"Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2022-01-03","conditions":"Presbyopia","enrollment":123},{"nctId":"NCT00988988","phase":"PHASE4","title":"The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate Injections","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2010-02","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT06000514","phase":"PHASE1, PHASE2","title":"Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.","status":"COMPLETED","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2019-01-17","conditions":"Cutaneous Leishmaniasis, American","enrollment":20},{"nctId":"NCT05119920","phase":"PHASE2","title":"Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2022-01-03","conditions":"Dry Eye Disease, Kerato Conjunctivitis Sicca","enrollment":226},{"nctId":"NCT05044936","phase":"EARLY_PHASE1","title":"Topical Cannabidiol Cream and Post-exercise Recovery","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2023-05-15","conditions":"Muscle Damage","enrollment":""},{"nctId":"NCT03658616","phase":"PHASE3","title":"Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.","status":"COMPLETED","sponsor":"Dr. August Wolff GmbH & Co. KG Arzneimittel","startDate":"2018-09-18","conditions":"Primary Axillary Hyperhidrosis","enrollment":518},{"nctId":"NCT05819983","phase":"PHASE4","title":"Ivermectin/ Permethrin for Scabies","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2023-01-25","conditions":"Scabies","enrollment":60},{"nctId":"NCT05300542","phase":"NA","title":"Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema","status":"COMPLETED","sponsor":"Amazentis SA","startDate":"2022-03-17","conditions":"Erythema, Sun Damaged Skin, Skin Inflammation","enrollment":22},{"nctId":"NCT05300984","phase":"NA","title":"Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product","status":"COMPLETED","sponsor":"Amazentis SA","startDate":"2022-03-15","conditions":"Skin Aging","enrollment":48},{"nctId":"NCT05078827","phase":"PHASE3","title":"Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Encube Ethicals Pvt. Ltd.","startDate":"2022-03-01","conditions":"Actinic Keratoses","enrollment":458}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":61,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo","vehicle","magnesium silicate","topical anesthesia","dressing"],"phase":"marketed","status":"active","brandName":"Placebo topical cream","genericName":"Placebo topical cream","companyName":"Sun Pharmaceutical Industries, Inc.","companyId":"sun-pharmaceutical-industries-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}